The Cancer Test - SA's first pan-tumour blood based biomarker is rated 3 out of 5 in the category medical practice. Read and write reviews about The Cancer Test - SA's first pan-tumour blood based biomarker. *Effective oncology treatment monitoring *Early detection of relapse Measures human progastrin in plasma. A prohormone secreted by tumour cells, and massively by cancer stem cells, hPG80 (Progastrin) regulates signalling pathways known to modulate cancer cell survival. hPG80 contributes to maintaining a tumour micro-environment that favours cancer cell malignancy. The fact that this prohormone is not secreted by healthy cells makes it a valuable tool that can be used by physicians to help them monitor treatment efficacy and detect early relapse of patients in remission.
Company size
1-10 employees